SITE008-0142

SITE008 (KOR) › SITE008-0142

SITE008-0142

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE008 (KOR) · Dr. Kim
consented 2026-02-09

enrolled

AEs

4

Serious

1

Dropout signal

–

Adverse events

4

Grade 3 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-12-03 (study day 102); relationship: NOT RELATED; serious criteria: hospitalization

severe serious assessed

Grade 1 Anaemia — outcome: UNKNOWN; onset 2022-11-20 (study day 89); relationship: not assessed

mild assessed

Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-11-12 (study day 81); relationship: NOT RELATED

moderate assessed

Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-10-16 (study day 54); relationship: RELATED

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.